BioCardia (NASDAQ:BCDA – Get Free Report) is projected to release its earnings data before the market opens on Wednesday, ...
After IPTW adjustment, OAC discontinuation was linked to a higher incidence of thromboembolism (0.86 vs. 0.37 per 100 ...
Heart failure is a serious, chronic condition. While medication can help the heart recover and improve its function, this study suggests that the medications themselves may continue to protect the ...
More and more people are talking about Novartis over the last few weeks. Is it worth buying the Pharmaceutical stock at a price of $112.13? Only time will tell. The information below will give you a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results